Our site uses cookies to make navigation as functional as possible, including "third party" cookies and "profiling cookies" designed to tailor on-line contents to suit the preferences expressed while surfing the internet. Should you wish to receive more information, or deny your consent to some or all cookies,
click here
. If you proceed browsing this website, you will be consenting to the use of all cookies.
More info
ita
eng
Our Group
Innovation & Research
Therapy and Wellness
Menarini News
Values
Careers
Home
Home
Menarini News
News
News
News details
News archive
Article details
Menarini partner della 40esima edizione del Premio Ischia
Project for network of pediatricians against child abuse
Fair Play Menarini International Awards
Fair Play Menarini International Awards 2019
Fair Play Menarini International Awards 2018
Gallery
Fair Play Menarini International Awards 2017
Press Release Awards
Fair Play Menarini International Awards 2016
Fair Play Menarini International Awards 2020
The 2016 Children's festival in Florence
100 Years in Florence
Menarini Proud Joy
The 2015 Children's Festival in Florence
100 YEARS WITH PONTORMO
Menarini International Fair Play Awards: Menarini celebrates 100 years in Florenece in the name of fair play
Press Room
Media Contact
Media Contact
Video
EFPIA - We Won't Rest Campaign
MENARINI and FARMINDUSTRIA: together we won't rest
Newsletter Subscribe
News
22 Jan 2021
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) Awareness Day
23 rd January 2021 marks the second annual BPDCN Awareness Day (#BPDCNday) since it received its own classification as a distinct hematologic malignancy by the World Health Organization (WHO).
Read more
21 Jan 2021
Menarini Receives European Commission Approval of ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
ELZONRIS is the first approved treatment for patients with BPDCN, and the first approved CD123-targeted therapy, in Europe.
Read more
16 Dec 2020
Menarini Group awarded the coveted XV Transatlantic Award from American Chamber of Commerce in Italy
Read more
01 Dec 2020
Menarini Ricerche Announces SEL24/MEN1703 Pharmacodynamic Data from the Dose Escalation Part of DIAMOND-01 Trial
SEL24/MEN1703 is being Evaluated for the Treatment of Acute Myeloid Leukemia (AML) Poster Accepted for Presentation at the 62nd American Society of Hematology (ASH) Annual Meeting
Read more
17 Sep 2020
Menarini Ricerche Announces Dose Escalation Results of the Clinical Trial of MEN1611 in Breast Cancer
Menarini Ricerche today announced the results of the dose escalation part of its B-PRECISE-01 clinical trial (NCT03767335) which is evaluating MEN1611,
Read more
16 Sep 2020
Menarini Ricerche Announces Initiation of Cohort Expansion for the Clinical Study of SEL24/MEN1703 in Acute Myeloid Leukemia
Menarini Ricerche, the R&D division of the Menarini Group, announced today that it has treated the first patient in Europe for the cohort expansion part of DIAMOND-01 clinical trial
Read more
Page 1 of 5
First
Previous
[1]
2
3
4
5
Next
Last
MENARINI PILLS OF ART
Concession granted by Italian Ministry for Cultural Heritage and Activities
Read more